Prognosis of Upfront Surgery for Pancreatic Cancer: A Systematic Review and Meta-Analysis of Prospective Studies

BACKGROUND: The rate of patients with pancreatic ductal adenocarcinoma (PDAC) receiving neoadjuvant chemotherapy is increasing, but upfront resection is still offered to most patients with resectable or borderline resectable disease. Encouraging data reported in adjuvant chemotherapy trials prompts...

Descripción completa

Detalles Bibliográficos
Autores principales: Pecorelli, Nicolò, Licinio, Alice W., Guarneri, Giovanni, Aleotti, Francesca, Crippa, Stefano, Reni, Michele, Falconi, Massimo, Balzano, Gianpaolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784375/
https://www.ncbi.nlm.nih.gov/pubmed/35083158
http://dx.doi.org/10.3389/fonc.2021.812102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784375/
https://www.ncbi.nlm.nih.gov/pubmed/35083158
http://dx.doi.org/10.3389/fonc.2021.812102

Ejemplares similares